The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of Schizophrenia
- PMID: 36428507
- PMCID: PMC9687986
- DOI: 10.3390/biomedicines10112939
The Impact of Antipsychotic Treatment on Neurological Soft Signs in Patients with Predominantly Negative Symptoms of Schizophrenia
Abstract
Schizophrenia is a complex and incompletely elucidated pathology that affects sensorimotor function and also produces numerous therapeutic challenges. The aims of this cross-sectional study were to identify the profile of neurological soft signs (NSS) in patients with predominantly negative symptoms of schizophrenia (PNS) compared with patients with schizophrenia who do not present a predominance of negative symptoms (NPNS) and also to objectify the impact of treatment on the neurological function of these patients. Ninety-nine (n = 99; 56 females and 43 males) patients diagnosed with schizophrenia according to DSM-V were included; these patients were undergoing antipsychotic (4 typical antipsychotics, 86 atypical antipsychotics, and 9 combinations of two atypical antipsychotics) or anticholinergic treatment (24 out of 99) at the time of evaluation, and the PANSS was used to identify the patients with predominantly negative symptoms (n = 39), the Neurological Evaluation Scale (NES) was used for the evaluation of neurological soft signs (NSS), and the SAS was used for the objectification of the extrapyramidal side effects induced by the neuroleptic treatment, which was converted to chlorpromazine equivalents (CPZE). The study's main finding was that, although the daily dose of CPZE did not represent a statistically significant variable, in terms of neurological soft signs, patients with PNS had higher rates of NSS.
Keywords: antipsychotics; neurological abnormalities; neurological soft signs; schizophrenia.
Conflict of interest statement
All the authors have read and approved the final manuscript, and they confirm that there are no conflicts of interest.
Figures










Similar articles
-
[Neurological soft signs in early onset schizophrenia].Encephale. 2015 Jun;41(3):209-14. doi: 10.1016/j.encep.2014.01.005. Epub 2014 May 20. Encephale. 2015. PMID: 24854724 French.
-
12-Month stability of neurological soft signs in stabilized patients with schizophrenia.Nord J Psychiatry. 2019 Oct;73(7):451-461. doi: 10.1080/08039488.2019.1649724. Epub 2019 Aug 8. Nord J Psychiatry. 2019. PMID: 31393751
-
[Minor neurological and physical anomalies in patients with first-episode psychosis].Encephale. 2013 Jun;39(3):149-54. doi: 10.1016/j.encep.2012.06.030. Epub 2012 Oct 12. Encephale. 2013. PMID: 23095597 French.
-
Neurological Soft Signs in Schizophrenia: An Update on the State- versus Trait-Perspective.Front Psychiatry. 2018 Jan 8;8:272. doi: 10.3389/fpsyt.2017.00272. eCollection 2017. Front Psychiatry. 2018. PMID: 29375401 Free PMC article. Review.
-
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5. Encephale. 2005. PMID: 15959450 Review. French.
Cited by
-
Neurological soft signs in neurodegenerative dementias: Results of the DemeNSS study.PCN Rep. 2025 Jun 25;4(2):e70143. doi: 10.1002/pcn5.70143. eCollection 2025 Jun. PCN Rep. 2025. PMID: 40567948 Free PMC article.
-
Clinical and Sociodemographic Correlations with Neurological Soft Signs in Hospitalized Patients with Schizophrenia: A Preliminary Longitudinal Study.Biomedicines. 2024 Apr 3;12(4):787. doi: 10.3390/biomedicines12040787. Biomedicines. 2024. PMID: 38672143 Free PMC article.
-
Exploring the longitudinal course of motor dexterity in first-episode psychosis: a 10-year follow-up.Eur Arch Psychiatry Clin Neurosci. 2024 Nov 6. doi: 10.1007/s00406-024-01937-2. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2024. PMID: 39503784
-
Neurological Soft Signs in Schizophrenia, a Picture of the Knowledge in the Last Decade: A Scoping Review.Healthcare (Basel). 2023 May 18;11(10):1471. doi: 10.3390/healthcare11101471. Healthcare (Basel). 2023. PMID: 37239757 Free PMC article.
References
-
- Kandel E.R., Schwartz J.H., Jessel T.M., Siegelbaum S. Principles of Neural Sciences. 4th ed. McGraw—Hill Medical; New York, NY, USA: 2000.
-
- Nasrallah H.A., Weinberger D.R. The Neurology of Schizophrenia. BV; Amsterdam, The Netherlands: 1986.
LinkOut - more resources
Full Text Sources